학술논문
Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer
Document Type
Article
Author
Naranbhai, V.; Gainor, J.F.; Iafrate, A.J.; St. Denis, K.J.; Lam, E.C.; Garcia-Beltran, W.F.; Balazs, A.B.; Ofoman, O.; Mairena, C.B.; Bhan, A.K.; Sullivan, R.J.; Bardia, A.; Spring, L.M.; Isakoff, S.J.; Farmer, J.R.; Zubiri, L.; Hobbs, G.S.; How, J.; Brunner, A.M.; Fathi, A.T.; Pernat, C.A.; Gavralidis, A.; Peterson, J.L.; Sakhi, M.; Hambelton, G.; Denault, E.N.; Mortensen, L.J.; Periello, L.A.; Bruno, M.N.; Bruno, M.N.; Betraux, B.Y.; Lawless, A.R.; Jackson, M.A.; Niehoff, E.; Barabell, C.; Nambu, C.N.; Nakajima, E.; Reinecke, T.; Bowes, C.; Kirkpatrick, G.E.; Thierauf, J.C.; Reynolds, K.; Willers, H.; Dighe, A.S.; Saff, R.; Blumenthal, K.
Source
In: Cancer Cell . (Cancer Cell, 10 January 2022, 40(1):103-108.e2)
Subject
Language
English
ISSN
18783686
15356108
15356108